North America Diabetic Foot Ulcer Market Forecast to 2030

North America Diabetic Foot Ulcer Market Forecast to 2030

North America Diabetic Foot Ulcer Market Forecast to 2030 – Regional Analysis -By Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers, and Neuro-ischemic Ulcers), Treatment Type (Advanced Wound Care Dressings, Biologics, and Therapy Device), Infection Severity (Moderate, Mild, and Severe), and End User (Hospitals, Ambulatory Surgery Centers, and Home Care)

Send Enquiry
Item ID: BMIRE00029570 Category: Tag:

$2,485 – $3,885

Description

The North America diabetic foot ulcer market was valued at US$ 3,570.76 million in 2022 and is expected to reach US$ 5,943.56 million by 2030; it is estimated to grow at a CAGR of 6.6% from 2022 to 2030.

Use of 3D Printing in Wound Care Management Fuels the North America Diabetic Foot Ulcer Market.

Skin tissue damage caused by various indications due to diabetes and vascular diseases significantly burdens the healthcare systems. 3D bioprinting is based on layer-based synthesis, wherein the newly generated cells and cell-based materials can be dispensed to mimic native tissues. Though the technology is still nascent, 3D printing can potentially revolutionize the wound care industry. Many companies are involved in developing new products involving ion-release biomaterials that promote angiogenesis for dermal regeneration. In addition, 3D bioprinting helps patch large wounds that are hard to heal with standard techniques. The use of 3D bioprinting technologies in ulcer or wound treatments is likely to emerge as a prominent trend in the diabetic foot ulcer market in the coming years.

North America Diabetic foot ulcer Market Overview

The North America diabetic foot ulcer market is estimated to grow at a CAGR of 6.64% from 2022 to 2030. Key factors driving the market growth are increasing prevalence of diabetes and related chronic wounds and the rise in geriatric population propel market growth. However, high cost of advanced wound care treatments hinders the market growth. The growing geriatric population in the region also boosts the market growth. According to the Administration on Aging (US Department of Health and Human Services) report published in 2022, there were 55.7 million people aged 65 and above in 2020 in the US. The old age group represents 17% of the population, i.e., 1 in every 6 Americans. As per estimates by the Urban Institute (Washington, DC-based think tank), the number of people aged 65 and older will double over the next 40 years, reaching 80 million in 2040 in the US. Additionally, in 2020, diabetes is regarded as among the leading chronic conditions among adults aged 65 and above.

In recent years, several joint ventures, initiatives, and collaborations contributed to accelerating the diabetic foot ulcers market expansion in North America. For instance, in 2020, six research institutions in the US launched the first-ever multicenter network funded by the National Institutes of Health to study diabetic foot ulcers in the US. Additionally, the Diabetic Foot Canada program was launched in Canada to prevent diabetic foot complications. Thus, the high prevalence of diabetes and the increasing geriatric population will drive the market growth in the region.

North America Diabetic foot ulcer Market Revenue and Forecast to 2030 (US$ Million)

North America Diabetic Foot Ulcer Market Segmentation

Based on treatment type, the North America diabetic foot ulcer market is segmented into advanced wound care dressings, therapy device, and biologics. The advanced wound care dressings segment held largest share in 2022.

Based on ulcer type, the North America diabetic foot ulcer market is segmented into neuro-lschemic ulcers, neuropathic ulcers, and ischemic ulcers. The neuro-lschemic ulcers segment held largest share in 2022.

Based on infection severity, the North America diabetic foot ulcer market is segmented into mild, moderate, and severe. The mild segment held largest share in 2022.

Based on end user, the North America diabetic foot ulcer market is segmented into hospitals, ambulatory surgical centers, and home care. The hospitals segment held largest share in 2022.

Based on country, the North America diabetic foot ulcer market is segmented into US, Canada, and Mexico. The US dominated North America diabetic foot ulcer market in 2022.

Convatec Group Plc, 3M Co, Coloplast AS, Smith & Nephew Plc, B. Braun SE, Medline Industries LP, Organogenesis Inc., Mölnlycke Health Care AB, and MiMedx Group Inc are some of the leading companies operating in the North America diabetic foot ulcer market.

Summary Info

Industry:

Pricing options:

, ,

Publishing status:

Geographical coverage:

Year of Publication:

At 6.6% CAGR, the North America Diabetic Foot Ulcer Market is speculated to be worth US$ 5,943.56 million by 2030, says The Research Team.

According to The Research Team’ research, the North America diabetic foot ulcer market was valued at US$ 3,570.76 in 2022 and is expected to reach US$ 5,943.56 million by 2030, registering a CAGR of 6.6% from 2022 to 2030. High prevalence of diabetes and related chronic wounds is among the critical factors attributed to the North America diabetic foot ulcer market expansion.

Diabetic patients are vulnerable to wounds, and the healing process is usually longer. Depending on healing timeframe, wounds are classified as acute and chronic. Diabetes is a life-threatening chronic disease with no functional cure. Diabetes can lead to various complications in different body parts and increase the overall risk of premature death. According to the International Diabetes Federation (IDF), in 2021, there were ∼537 million adults living with diabetes worldwide. The number is anticipated to increase to 643 million by 2030 and 783 million by 2045. Blood vessels and nerves in the feet of diabetic patients are prone to damages, resulting in numbness. Due to this, diabetic patients have a higher chance of developing diabetic foot ulceration. According to a study published in 2021 in National Center for Biotechnology Information (NCBI), the risk of developing diabetic foot ulcers is between 19% and 34%. Approximately, a recurrence rate of 40% is experienced by patients within 1 year of recovery, 60% within 3 years, and 65% within 5 years. As per same study, it is reported that infection develops in 50–60% of ulcers and is the principal cause that damages diabetic feet. Thus, the demand for diabetic foot ulcer treatments is on rise globally, thereby fueling the market growth.

On the contrary, high cost of advanced wound care treatments hampers the growth North America diabetic foot ulcer market.

Based on treatment type, the North America diabetic foot ulcer market is segmented into advanced wound care dressings, therapy device, and biologics. The advanced wound care dressings segment held 54.6% share of the North America diabetic foot ulcer market in 2022, amassing US$ 1,948.60 million. It is projected to garner US$ 3,301.93 million by 2030 to expand at 6.8% CAGR during 2022-2030.

Based on ulcer type, the North America diabetic foot ulcer market is segmented into neuro-lschemic ulcers, neuropathic ulcers, and ischemic ulcers. The neuro-lschemic ulcers segment held 50.6% share of the North America diabetic foot ulcer market in 2022, amassing US$ 1,808.24 million. It is projected to garner US$ 3,083.57 million by 2030 to expand at 6.9% CAGR during 2022–2030.

Based on infection severity, the North America diabetic foot ulcer market is segmented into mild, moderate, and severe. The mild segment held 47.3% share of North America diabetic foot ulcer market in 2022, amassing US$ 1,689.89 million. It is projected to garner US$ 2,902.59 million by 2030 to expand at 7.0% CAGR during 2022–2030.

Based on end user, the North America diabetic foot ulcer market is segmented into hospitals, ambulatory surgical centers, and home care. The hospitals segment held 56.9% share of North America diabetic foot ulcer market in 2022, amassing US$ 2,032.45 million. It is projected to garner US$ 3,504.99 million by 2030 to expand at 7.0% CAGR during 2022–2030.

Based on country, the North America diabetic foot ulcer market is segmented into US, Canada, and Mexico. The US held 85.4% share of North America diabetic foot ulcer market in 2022, amassing US$ 3,049.79 million. It is projected to garner US$ 5,122.75 million by 2030 to expand at 6.7% CAGR during 2022–2030.

Key players operating in the North America diabetic foot ulcer market are Convatec Group Plc, 3M Co, Coloplast AS, Smith & Nephew Plc, B. Braun SE, Medline Industries LP, Organogenesis Inc., Mölnlycke Health Care AB, and MiMedx Group Inc, among others.

In Jul 2022, Smith+Nephew announced the launch of the WOUND COMPASS Clinical Support App. It is a comprehensive digital support tool for healthcare professionals that aids wound assessment and decision-making to help reduce practice variation. The App helps improve nurse confidence when assessing and treating wounds and reassuring specialist nurses that their formulary is followed. In Jul 2023, MiMedx Group, Inc. announced a strategic realignment designed to focus the Company’s resources on accelerating its Wound & Surgical business growth, driving profitability, and enhancing cash flow generation.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America diabetic foot ulcer treatment market.
o Highlights key business priorities in order to assist companies to realign their business strategies
o The key findings and recommendations highlight crucial progressive industry trends in the North America diabetic foot ulcer treatment market, thereby allowing players across the value chain to develop effective long-term strategies
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
o Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America diabetic foot ulcer treatment market, as well as those hindering it
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

TABLE OF CONTENTS


1. Introduction
1.1 The Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Diabetic Foot Ulcer Market Landscape
4.1 Overview
5. North America Diabetic Foot Ulcer Market – Key Industry Dynamics
5.1 Market Drivers:
5.1.1 High Prevalence of Diabetes and Related Chronic Wounds
5.1.2 Surge in Geriatric Population
5.2 Market Restraints
5.2.1 High Cost of Advanced Wound Care Treatments
5.3 Market Opportunities
5.3.1 Growing Research Activities to Unveil Novel Wound Treatment Products
5.4 Future Trends
5.4.1 Use of 3D Printing in Wound Care Management
5.5 Impact Analysis:
6. Diabetic Foot Ulcer Market – North America Market Analysis
6.1 North America Diabetic Foot Ulcer Market Revenue (US$ Mn), 2022 – 2030
7. North America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 – by Treatment Type
7.1 Overview
7.2 North America Diabetic Foot Ulcer Market Revenue Share, by Treatment Type 2022 & 2030 (%)
7.3 Advanced Wound Care Dressings
7.3.1 Overview
7.3.2 Advanced Wound Care Dressings: North America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.3.3 Alginate Dressings
7.3.3.1 Overview
7.3.3.2 Alginate Dressings: North America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.3.4 Hydrofiber Dressings
7.3.4.1 Overview
7.3.4.2 Hydrofiber Dressings: North America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.3.5 Foam Dressings
7.3.5.1 Overview
7.3.5.2 Foam Dressings: North America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.3.6 Collagen Dressing
7.3.6.1 Overview
7.3.6.2 Collagen Dressing: North America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.3.7 Film Dressing
7.3.7.1 Overview
7.3.7.2 Film Dressing: North America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.3.8 Other Dressings
7.3.8.1 Overview
7.3.8.2 Other Dressing: North America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Biologics
7.4.1 Overview
7.4.2 Biologics: North America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.4.3 Growth Factors
7.4.3.1 Overview
7.4.3.2 Growth Factors: North America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.4.4 Skin Graft
7.4.4.1 Overview
7.4.4.2 Skin Graft: North America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Therapy Device
7.5.1 Overview
7.5.2 Therapy Device: North America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.5.3 Negative Pressure Wound Therapy
7.5.3.1 Overview
7.5.3.2 Negative Pressure Wound Therapy: North America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.5.4 Ultrasound Therapy
7.5.4.1 Overview
7.5.4.2 Ultrasound Therapy: North America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
8. North America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 – By Ulcer Type
8.1 Overview
8.2 North America Diabetic Foot Ulcer Market Revenue Share, By Ulcer Type 2022 & 2030 (%)
8.3 Neuropathic Ulcers
8.3.1 Overview
8.3.2 Neuropathic Ulcers: North America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Ischemic Ulcers
8.4.1 Overview
8.4.2 Ischemic Ulcers: North America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Neuro-ischemic Ulcers
8.5.1 Overview
8.5.2 Neuro-ischemic Ulcers: North America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
9. North America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 – By Infection Severity
9.1 Overview
9.2 North America Diabetic Foot Ulcer Market Revenue Share, By Infection Severity 2022 & 2030 (%)
9.3 Mild, Moderate, and Severe
9.3.1 Overview
9.3.2 Mild: North America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
9.3.3 Moderate: North America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
9.3.4 Severe: North America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
10. North America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 – By End User
10.1 Overview
10.2 North America Diabetic Foot Ulcer Market Revenue Share, By End User 2022 & 2030 (%)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals: North America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Ambulatory Surgical Centers
10.4.1 Overview
10.4.2 Ambulatory Surgical Centers: North America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
10.5 Home Care
10.5.1 Overview
10.5.2 Home Care: North America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
11. Diabetic Foot Ulcer Market – North America Market Analysis
11.1 North America Diabetic Foot Ulcer Market, Revenue and Forecast To 2030
11.1.1 Overview
11.1.1.1 North America Diabetic Foot Ulcer Market, by Country
11.1.1.2 US
11.1.1.2.1 US Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.2.2 US Diabetic Foot Ulcer Market, by Ulcer Type
11.1.1.2.3 US Diabetic Foot Ulcer Market, by Treatment Type
11.1.1.2.3.1 US: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.1.1.2.3.2 US: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.1.1.2.3.3 US: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.1.1.2.4 US Diabetic Foot Ulcer Market, by Infection Severity
11.1.1.2.5 US Diabetic Foot Ulcer Market, by End User
11.1.1.3 Canada
11.1.1.3.1 Canada Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.3.2 Canada Diabetic Foot Ulcer Market, by Ulcer Type
11.1.1.3.3 Canada Diabetic Foot Ulcer Market, by Treatment Type
11.1.1.3.3.1 Canada: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.1.1.3.3.2 Canada: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.1.1.3.3.3 Canada: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.1.1.3.4 Canada Diabetic Foot Ulcer Market, by Infection Severity
11.1.1.3.5 Canada Diabetic Foot Ulcer Market, by End User
11.1.1.4 Mexico
11.1.1.4.1 Mexico Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.4.2 Mexico Diabetic Foot Ulcer Market, by Ulcer Type
11.1.1.4.3 Mexico Diabetic Foot Ulcer Market, by Treatment Type
11.1.1.4.3.1 Mexico: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.1.1.4.3.2 Mexico: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.1.1.4.3.3 Mexico: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.1.1.4.4 Mexico Diabetic Foot Ulcer Market, by Infection Severity
11.1.1.4.5 Mexico Diabetic Foot Ulcer Market, by End User
12. North America Diabetic Foot Ulcer Market Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Global Diabetic Foot Ulcer Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. North America Diabetic Foot Ulcer Market – Key Company Profiles
13.1 Convatec Group Plc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 3M Co
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Coloplast AS
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Smith & Nephew Plc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 B. Braun SE
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Molnlycke Health Care AB
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 MiMedx Group Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Medline Industries LP
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Organogenesis Inc.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms

LIST OF TABLES

Table 1. North America Diabetic Foot Ulcer Market Segmentation
Table 2. Middle East & Africa Diabetic Foot Ulcer Market, by Country – Revenue and Forecast to 2030 (USD Million)
Table 3. US Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn) – Ulcer Type
Table 4. US Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn) – Treatment Type
Table 5. US: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2030 (USD Million)
Table 6. US: Diabetic Foot Ulcer Market, by Therapy Device- Revenue and Forecast to 2030 (USD Million)
Table 7. US: Diabetic Foot Ulcer Market, by Biologics- Revenue and Forecast to 2030 (USD Million)
Table 8. US Diabetic Foot Ulcer Market Revenue and Forecast To 2030 (US$ Mn) – Infection Severity
Table 9. US Diabetic Foot Ulcer Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 10. Canada Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn) – Ulcer Type
Table 11. Canada Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn) – Treatment Type
Table 12. Canada: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2030 (USD Million)
Table 13. Canada: Diabetic Foot Ulcer Market, by Therapy Device- Revenue and Forecast to 2030 (USD Million)
Table 14. Canada: Diabetic Foot Ulcer Market, by Biologics- Revenue and Forecast to 2030 (USD Million)
Table 15. Canada Diabetic Foot Ulcer Market Revenue and Forecast To 2030 (US$ Mn) – Infection Severity
Table 16. Canada Diabetic Foot Ulcer Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 17. Mexico Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn) – Ulcer Type
Table 18. Mexico Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn) – Treatment Type
Table 19. Mexico: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2030 (USD Million)
Table 20. Mexico: Diabetic Foot Ulcer Market, by Therapy Device- Revenue and Forecast to 2030 (USD Million)
Table 21. Mexico: Diabetic Foot Ulcer Market, by Biologics- Revenue and Forecast to 2030 (USD Million)
Table 22. Mexico Diabetic Foot Ulcer Market Revenue and Forecast To 2030 (US$ Mn) – Infection Severity
Table 23. Mexico Diabetic Foot Ulcer Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 24. Recent Inorganic Growth Strategies in the Global Diabetic Foot Ulcer Market
Table 25. Recent Organic Growth Strategies in the Global Diabetic Foot Ulcer Market
Table 26. Glossary of Terms, Diabetic Foot Ulcer Market

LIST OF FIGURES

Figure 1. North America Diabetic Foot Ulcer Market Segmentation, By Country
Figure 2. North America Diabetic Foot Ulcer Market – Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. North America Diabetic Foot Ulcer Market Revenue (US$ Mn), 2022 – 2030
Figure 5. North America Diabetic Foot Ulcer Market Revenue Share, by Treatment Type 2022 & 2030 (%)
Figure 6. Advanced Wound Care Dressings: North America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Alginate Dressings: North America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Hydrofiber Dressings: North America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Foam Dressings: North America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Collagen Dressing: North America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Film Dressing: North America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Other Dressing: North America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Biologics: North America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Growth Factors: North America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Skin Graft: North America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Therapy Device: North America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Negative Pressure Wound Therapy: North America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Ultrasound Therapy: North America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. North America Diabetic Foot Ulcer Market Revenue Share, By Ulcer Type 2022 & 2030 (%)
Figure 20. Neuropathic Ulcers: North America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Ischemic Ulcers: North America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Neuro-ischemic Ulcers: North America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. North America Diabetic Foot Ulcer Market Revenue Share, By Infection Severity 2022 & 2030 (%)
Figure 24. Mild: North America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Moderate: North America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Severe: North America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. North America Diabetic Foot Ulcer Market Revenue Share, By End User 2022 & 2030 (%)
Figure 28. Hospitals: North America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Ambulatory Surgical Centers: North America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 30. Home Care: North America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 31. North America Diabetic Foot Ulcer Market, By Key Countries 2022 (US$Mn)
Figure 32. North America Diabetic Foot Ulcer Market, By Key Countries, 2022 and 2030 (%)
Figure 33. US Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
Figure 34. Canada Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
Figure 35. Mexico Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
Figure 36. Growth Strategies in the Global Diabetic Foot Ulcer Market

The List of Companies – North America Diabetic Foot Ulcer Market

1. Convatec Group Plc
2. 3M Co
3. Coloplast AS
4. Smith & Nephew Plc
5. B. Braun SE
6. Medline Industries LP
7. Organogenesis Inc.
8. Mölnlycke Health Care AB
9. MiMedx Group Inc

Reviews

There are no reviews yet.

Be the first to review “North America Diabetic Foot Ulcer Market Forecast to 2030”